We summarize here lessons learned from studies on skeletal and extra-skeletal functions of vitamin D in hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR) patients with a mutant, nonfunctioning vitamin D receptor (VDR). During childhood, HVDRR patients are dependent on intestinal VDR, demonstrate low intestinal fraction calcium absorption, and have a bone calcium accretion rate that leads to hypocalcemia and rickets. After puberty, there is recovery in intestinal calcium absorption and in bone calcium accretion and structure. HVDRR monocytes and lymphocytes show impairment in the expression of antimicrobial proteins and demonstrate a proinflammatory cytokine profile. However, HVDRR patients do not exhibit increased rates of infections or inflammatory diseases. Vitamin D deficiency is associated with asthmatic exacerbations. Surprisingly, HVDRR patients do not usually develop asthma. They have normal allergic tests and lung functions and are protected against provoked bronchial hyperactivity. HVDRR patients have decreased IL-5 levels in their exhaled breath condensate. Given that IL-5 is a key cytokine in the development of airway inflammation and hyperactivity and that VDR is important for IL-5 generation, it is plausible that low lung IL-5 protects HVDRR patients from asthma. Vitamin D metabolites have suppressive effects on the renin angiotensin system. However, no HVDRR patient showed hypertension or echocardiographic pathology, and their renin angiotensin metabolites were normal. The VDR is expressed throughout the reproductive system, suggesting a role in reproduction. However, the reproductive history of HVDRR patients is normal despite the lack of a normal VDR. HVDRR patients provide a unique opportunity to study the role of the VDR and the role of vitamin D in various human systems.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jn/nxaa380DOI Listing

Publication Analysis

Top Keywords

hvdrr patients
32
hvdrr
10
patients
9
lessons learned
8
hereditary 125-dihydroxyvitamin
8
125-dihydroxyvitamin d-resistant
8
d-resistant rickets
8
calcium absorption
8
absorption bone
8
bone calcium
8

Similar Publications

The care of the patient with X-linked hypophosphatemic rickets.

Eur J Paediatr Dent

December 2024

Department of Surgical, Medical, Molecular and Critical Area Pathology, Unit of Pediatric Dentistry, University of Pisa, Pisa, Italy.

Article Synopsis
  • - The study investigates dental issues in patients with X-linked hypophosphatemic rickets (XLH), focusing on abscess occurrence and the characteristics of pulp chambers.
  • - Researchers analyzed 24 XLH patients and 23 healthy controls, using imaging and histological techniques to compare pulp chamber features and dental health.
  • - Results showed that most XLH patients have enlarged and altered pulp chambers, increasing their risk for abscesses, highlighting the need for early, multidisciplinary dental care for these patients.
View Article and Find Full Text PDF

Metabolic bone diseases are a heterogenous group of conditions that all result in aberrant bone mineral homeostasis with resulting skeletal disease. The underlying causes are variable, ranging from nutritional deficiencies to pathogenic variants in skeletal genes. To properly diagnose and treat these conditions, a clinician needs to understand bone metabolism as well as recognize the signs of disease in a patient.

View Article and Find Full Text PDF

Tertiary hyperparathyroidism in two paediatric patients with X-linked hypophosphatemia during Burosumab treatment.

Bone

January 2025

Department of Paediatric Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address:

Article Synopsis
  • Secondary hyperparathyroidism is common in X-linked hypophosphatemia (XLH) patients, but the occurrence of tertiary hyperparathyroidism with hypercalcemia is rare, particularly in children, as seen in two reported cases.
  • The first case involved a female patient who transitioned to Burosumab treatment, developed tertiary hyperparathyroidism at 14 years, and successfully resolved her hypercalcemia post-parathyroidectomy. In contrast, the second patient faced both secondary and tertiary hyperparathyroidism after switching to Burosumab, requiring surgery and ongoing treatment with Cinacalcet to manage her condition.
  • The underlying cause of tertiary hyperparathyroidism in these cases is uncertain, suggesting potential issues with phosphate
View Article and Find Full Text PDF

Hypophosphatemic rickets is a rare metabolic bone disease caused by renal phosphate wasting, leading to impaired bone mineralization. We present a case of a boy with fibroblast growth factor 23 (FGF23)-related hypophosphatemic rickets who did not achieve callus consolidation after six months of conventional therapy with phosphate and active vitamin D following corrective osteotomy. After one month of therapy with an FGF23 antibody (burosumab), the patient demonstrated significant improvement and no longer required a walking aid.

View Article and Find Full Text PDF
Article Synopsis
  • X-linked hypophosphatemia (XLH) is a rare genetic disorder leading to skeletal issues, particularly affecting a patient's gait due to lower limb deformities, but standardized data on these deformities are lacking.
  • A study assessed lower limb maltorsion in children and adolescents with XLH, using advanced imaging techniques like MRI and CT to measure femoral and tibial torsion, acetabular anteversion, and hip coverage.
  • Results indicated that many patients exhibited abnormal femoral and tibial torsion; notably, 47% had decreased femoral torsion, and 64% presented reduced external tibial torsion, raising concerns about the impact of these deformities on walking
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!